STRIDES PHARMA SCIENCE
|
STRIDES PHARMA SCIENCE Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹5,327 Cr | ₹5,473 Cr | ₹4,711 Cr | ₹3,337 Cr | ₹2,845 Cr |
Sales | ₹5,213 Cr | ₹5,372 Cr | ₹4,600 Cr | ₹3,206 Cr | ₹2,628 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹66 Cr | ₹36 Cr | ₹16 Cr | ₹61 Cr | ₹169 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | ₹48 Cr | ₹65 Cr | ₹95 Cr | ₹70 Cr | ₹49 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹3,070 Cr | ₹3,316 Cr | ₹2,752 Cr | ₹2,178 Cr | ₹2,845 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹95 Cr | ₹-354 Cr | ₹-45 Cr | ₹-104 Cr | ₹92 Cr |
Raw Material Consumed | ₹1,407 Cr | ₹1,686 Cr | ₹1,167 Cr | ₹1,189 Cr | ₹1,287 Cr |
Opening Raw Materials | ₹552 Cr | ₹507 Cr | ₹415 Cr | ₹258 Cr | ₹289 Cr |
Purchases Raw Materials | ₹1,114 Cr | ₹1,435 Cr | ₹1,112 Cr | ₹1,159 Cr | ₹816 Cr |
Closing Raw Materials | ₹575 Cr | ₹552 Cr | ₹507 Cr | ₹415 Cr | ₹258 Cr |
Other Direct Purchases / Brought in cost | ₹316 Cr | ₹296 Cr | ₹147 Cr | ₹187 Cr | ₹439 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹72 Cr | ₹65 Cr | ₹64 Cr | ₹54 Cr | ₹51 Cr |
Electricity & Power | ₹72 Cr | ₹65 Cr | ₹64 Cr | ₹54 Cr | ₹50 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | ₹1.64 Cr |
Employee Cost | ₹647 Cr | ₹550 Cr | ₹443 Cr | ₹329 Cr | ₹434 Cr |
Salaries, Wages & Bonus | ₹528 Cr | ₹466 Cr | ₹375 Cr | ₹281 Cr | ₹367 Cr |
Contributions to EPF & Pension Funds | ₹55 Cr | ₹39 Cr | ₹32 Cr | ₹24 Cr | ₹32 Cr |
Workmen and Staff Welfare Expenses | ₹64 Cr | ₹38 Cr | ₹34 Cr | ₹23 Cr | ₹33 Cr |
Other Employees Cost | ₹-0.71 Cr | ₹6.80 Cr | ₹1.75 Cr | ₹0.90 Cr | ₹2.21 Cr |
Other Manufacturing Expenses | ₹256 Cr | ₹238 Cr | ₹211 Cr | ₹151 Cr | ₹116 Cr |
Sub-contracted / Out sourced services | ₹48 Cr | ₹45 Cr | ₹34 Cr | ₹28 Cr | ₹21 Cr |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹111 Cr | ₹89 Cr | ₹77 Cr | ₹48 Cr | ₹50 Cr |
Packing Material Consumed | - | - | - | - | - |
Other Mfg Exp | ₹96 Cr | ₹104 Cr | ₹100 Cr | ₹75 Cr | ₹46 Cr |
General and Administration Expenses | ₹224 Cr | ₹192 Cr | ₹192 Cr | ₹150 Cr | ₹194 Cr |
Rent , Rates & Taxes | ₹60 Cr | ₹66 Cr | ₹48 Cr | ₹52 Cr | ₹55 Cr |
Insurance | ₹21 Cr | ₹17 Cr | ₹13 Cr | ₹7.21 Cr | ₹11 Cr |
Printing and stationery | ₹3.61 Cr | ₹4.19 Cr | ₹4.50 Cr | ₹3.48 Cr | ₹4.73 Cr |
Professional and legal fees | ₹119 Cr | ₹87 Cr | ₹100 Cr | ₹65 Cr | ₹81 Cr |
Traveling and conveyance | ₹9.11 Cr | ₹6.28 Cr | ₹16 Cr | ₹13 Cr | ₹29 Cr |
Other Administration | ₹21 Cr | ₹17 Cr | ₹26 Cr | ₹22 Cr | ₹42 Cr |
Selling and Distribution Expenses | ₹331 Cr | ₹223 Cr | ₹137 Cr | ₹111 Cr | ₹209 Cr |
Advertisement & Sales Promotion | ₹18 Cr | ₹13 Cr | ₹11 Cr | ₹22 Cr | ₹78 Cr |
Sales Commissions & Incentives | ₹13 Cr | ₹9.78 Cr | ₹5.58 Cr | ₹9.94 Cr | ₹7.51 Cr |
Freight and Forwarding | ₹301 Cr | ₹200 Cr | ₹120 Cr | ₹79 Cr | ₹124 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | - | - | - | - | - |
Miscellaneous Expenses | ₹61 Cr | ₹89 Cr | ₹67 Cr | ₹55 Cr | ₹47 Cr |
Bad debts /advances written off | - | ₹9.46 Cr | ₹11 Cr | ₹6.25 Cr | - |
Provision for doubtful debts | - | - | - | - | ₹1.41 Cr |
Losson disposal of fixed assets(net) | - | - | ₹5.31 Cr | - | - |
Losson foreign exchange fluctuations | ₹9.78 Cr | - | ₹19 Cr | ₹13 Cr | ₹-12 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹51 Cr | ₹79 Cr | ₹31 Cr | ₹35 Cr | ₹58 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹3,092 Cr | ₹2,689 Cr | ₹2,236 Cr | ₹1,936 Cr | ₹2,431 Cr |
Operating Profit (Excl OI) | ₹-22 Cr | ₹627 Cr | ₹516 Cr | ₹242 Cr | ₹414 Cr |
Other Income | ₹133 Cr | ₹59 Cr | ₹53 Cr | ₹41 Cr | ₹76 Cr |
Interest Received | ₹107 Cr | ₹35 Cr | ₹37 Cr | ₹17 Cr | ₹9.01 Cr |
Dividend Received | - | - | ₹4.52 Cr | ₹8.43 Cr | ₹45 Cr |
Profit on sale of Fixed Assets | ₹11 Cr | ₹2.34 Cr | - | ₹1.13 Cr | ₹7.48 Cr |
Profits on sale of Investments | ₹0.29 Cr | ₹1.19 Cr | - | - | - |
Provision Written Back | ₹1.41 Cr | ₹0.75 Cr | - | - | ₹0.00 Cr |
Foreign Exchange Gains | - | ₹8.02 Cr | - | - | - |
Others | ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹14 Cr | ₹15 Cr |
Operating Profit | ₹112 Cr | ₹686 Cr | ₹569 Cr | ₹283 Cr | ₹491 Cr |
Interest | ₹177 Cr | ₹150 Cr | ₹156 Cr | ₹79 Cr | ₹196 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | ₹129 Cr | ₹109 Cr | ₹120 Cr | ₹67 Cr | ₹138 Cr |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | ₹31 Cr | ₹26 Cr | ₹21 Cr | ₹12 Cr | ₹59 Cr |
Other Interest | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹0.32 Cr | ₹0.00 Cr |
PBDT | ₹-65 Cr | ₹536 Cr | ₹413 Cr | ₹204 Cr | ₹294 Cr |
Depreciation | ₹233 Cr | ₹206 Cr | ₹174 Cr | ₹117 Cr | ₹154 Cr |
Profit Before Taxation & Exceptional Items | ₹-298 Cr | ₹330 Cr | ₹240 Cr | ₹86 Cr | ₹140 Cr |
Exceptional Income / Expenses | ₹-244 Cr | ₹43 Cr | ₹-78 Cr | ₹22 Cr | ₹-44 Cr |
Profit Before Tax | ₹-653 Cr | ₹275 Cr | ₹55 Cr | ₹62 Cr | ₹80 Cr |
Provision for Tax | ₹-178 Cr | ₹32 Cr | ₹11 Cr | ₹-27 Cr | ₹5.69 Cr |
Current Income Tax | ₹10 Cr | ₹29 Cr | ₹28 Cr | ₹30 Cr | ₹49 Cr |
Deferred Tax | ₹-17 Cr | ₹9.58 Cr | ₹-32 Cr | ₹-32 Cr | ₹-43 Cr |
Other taxes | ₹-172 Cr | ₹-6.94 Cr | ₹15 Cr | ₹-25 Cr | - |
Profit After Tax | ₹-474 Cr | ₹244 Cr | ₹43 Cr | ₹89 Cr | ₹74 Cr |
Extra items | - | ₹14 Cr | ₹-13 Cr | ₹241 Cr | ₹610 Cr |
Minority Interest | ₹14 Cr | ₹11 Cr | ₹5.80 Cr | ₹-5.26 Cr | ₹-20 Cr |
Share of Associate | - | - | - | - | - |
Other Consolidated Items | - | - | - | - | - |
Consolidated Net Profit | ₹-460 Cr | ₹268 Cr | ₹36 Cr | ₹325 Cr | ₹665 Cr |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹485 Cr | ₹234 Cr | ₹381 Cr | ₹135 Cr | ₹223 Cr |
Appropriations | ₹25 Cr | ₹503 Cr | ₹417 Cr | ₹460 Cr | ₹888 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | ₹18 Cr | - | - |
Other Appropriation | ₹22 Cr | ₹18 Cr | ₹58 Cr | ₹79 Cr | ₹753 Cr |
Equity Dividend % | - | ₹25.00 | ₹140.00 | ₹30.00 | ₹20.00 |
Earnings Per Share | ₹-51.25 | ₹29.93 | ₹4.06 | ₹36.25 | ₹74.25 |
Adjusted EPS | ₹-51.25 | ₹29.93 | ₹4.06 | ₹36.25 | ₹74.25 |
Compare Income Statement of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹8,118.9 Cr | 0.8% | 10% | 163.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹361,916.0 Cr | 0.3% | -7.5% | 53.9% | Stock Analytics | |
CIPLA | ₹115,034.0 Cr | 1.1% | -4.8% | 56.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,929.0 Cr | 1.6% | 1.6% | 27.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,873.0 Cr | -1.9% | 10.7% | 21.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹100,322.0 Cr | 5.2% | -0.2% | 90.1% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | 0.8% |
10% |
163.7% |
SENSEX | -0.6% |
0.3% |
21.8% |
You may also like the below Video Courses